Key result
New RCT protocol examines transcendental meditation effects on blood pressure and carotid body activity.
Why the study?
Evidence supports meditation as an adjunct therapy for hypertension, but its effects lack reliable physiological grounding regarding carotid body modulation.
Does transcendental meditation reduce blood pressure and modulate carotid body activity in adults with stage 1 hypertension?
RCT (n=72)
Researchers, lab personnel, and statistician blinded; participants unblinded to intervention but blinded to hypotheses and gas trials
Block randomization (block size 8) via computer-generated random numbers with 1:1 allocation
No
Does transcendental meditation reduce blood pressure and modulate carotid body activity in adults with stage 1 hypertension?
Answers are grounded in this paper and cite their sources.
This study protocol outlines a trial to evaluate whether transcendental meditation can effectively lower blood pressure through the modulation of carotid body activity in hypertensive patients.
Adjunctive therapy for hypertension is in high demand for clinical research. Therefore, several meta-analyses have provided sufficient evidence for meditation as an adjunct therapy, without being anchored on reliable physiological grounds. Meditation modulates the autonomic nervous system. Herein, we propose a hierarchical-dependent effect for the carotid body (CB) in attenuating blood pressure (BP) and ventilatory variability (VV) fine-tuning due to known nerve connections between the CB, prefrontal brain, hypothalamus, and solitary tract nucleus. The aim of this exploratory study was to investigate the role of CB in the possible decrease in BP and changes in VV that could occur in response to meditation. This was a prospective, single-center, parallel-group, randomized, controlled clinical trial with concealed allocation. Eligible adult subjects of both sexes with stage 1 hypertension will be randomized into 1 of 2 groups: transcendental meditation or a control group. Subjects will be invited to 3 visits after randomization and 2 additional visits after completing 8 weeks of meditation or waiting-list control. Thus, subjects will undergo BP measurements in normoxia and hyperoxia, VV measurements using the Poincaré method at rest and during exercise, and CB activity measurement in the laboratory. The primary outcome of this study was the detection of changes in BP and CB activity after 8 weeks. Our secondary outcome was the detection of changes in the VV at rest and during exercise. We predict that interactions between hyperoxic deactivation of CB and meditation; Will reduce BP beyond stand-alone intervention or alternatively; Meditation will significantly attenuate the effects of hyperoxia as a stand-alone intervention. In addition, VV can be changed, partially mediated by a reduction in CB activity. Trial registration number: ReBEC registry (RBR-55n74zm). Stage: pre-results.
No takes yet. Share an insight, caveat, or question.
Augusto et al. (2023) conducted an RCT in Stage 1 Hypertension (n=72). Transcendental meditation vs. Waiting-list control (standard pharmacological treatment) was evaluated on Changes in blood pressure and resting carotid body activity. As this is a study protocol, the effect of transcendental meditation on blood pressure and carotid body activity is not yet reported.
Synapse has enriched 10 related papers. Consider them for comparative context: